Observational Registry Data on GIST Patients
The Observational Registry: Nationwide Data Collection on Gastrointestinal Stromal Tumors (GISTs) Patients (Taiwan GISTs Registry)
1 other identifier
observational
3,000
1 country
1
Brief Summary
This is a longitudinal, multi-center, registry study, collecting data via a web-based portal in patients with GIST (Gastrointestinal Stromal Tumor) from hospitals in Taiwan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2018
CompletedFirst Posted
Study publicly available on registry
July 26, 2018
CompletedStudy Start
First participant enrolled
October 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMay 22, 2025
May 1, 2025
7.2 years
July 16, 2018
May 19, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
To establish the database for GIST
By register the clinical presentation, diagnostic, stage, treatment and clinical outcome of GIST patients.
From date of registration to 31 December 2025
Interventions
This is a longitudinal, multi-center, registry study, collecting data via a web-based portal in patients with GIST (Gastrointestinal Stromal Tumor) from hospitals in Taiwan.
Eligibility Criteria
Patients diagnosed with Gastrointestinal Stromal Tumor
You may qualify if:
- Patients diagnosed with Gastrointestinal Stromal Tumor
- ≥20 years old
- Histology-confirmed GIST between 01 January 2010 and 31 December 2020.
- Patient with prospective data collection: Willing to provide singed inform-consent as per local regulatory requirements.
You may not qualify if:
- Inability and unwillingness to give informed consent if required by site ethic committee.
- Patient that is unlikely candidate to obtain long-term follow-up information for reasons of unavailability or with severe concomitant illnesses per investigator judgement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Health Research Institutes, Taiwanlead
- Taipei Veterans General Hospital, Taiwancollaborator
- National Taiwan University Hospitalcollaborator
- China Medical University Hospitalcollaborator
- Changhua Christian Hospitalcollaborator
- Chang Gung Memorial Hospitalcollaborator
- National Cheng-Kung University Hospitalcollaborator
- Kaohsiung Medical Universitycollaborator
- Taichung Veterans General Hospitalcollaborator
Study Sites (1)
Yu wei-lan
Taipei, 10048, Taiwan
Biospecimen
C-KIT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Tsang-Wu Liu, M.D
Taiwan Cooperation Organization Group,NHRI,Taiwan
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 7 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2018
First Posted
July 26, 2018
Study Start
October 16, 2018
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
May 22, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share